Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan · Delayed Price · Currency is TWD 30.10
+0.15 (0.50%)
Aug 19, 2026, 1:30 PM CST
TPEX:4111 Market Cap
TPEX:4111 has a market cap or net worth of 1.8 billion as of August 19, 2026. Its market cap has decreased by -5.94% in one year.
Market Cap
1.80B
Enterprise Value
1.35B
Revenue
1.42B
Ranking
n/a
PE Ratio
9.62
Stock Price
30.10
ChartMarket Cap Chart
Since April 11, 2006, TPEX:4111's market cap has increased from 735.73M to 1.80B, an increase of 144.78%. That is a compound annual growth rate of 4.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.80B | 2.21% |
| Dec 31, 2025 | 1.76B | 11.23% |
| Dec 31, 2024 | 1.58B | 4.32% |
| Dec 29, 2023 | 1.52B | -1.66% |
| Dec 30, 2022 | 1.54B | 17.32% |
| Dec 30, 2021 | 1.32B | -3.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.40B |
| SciVision Biotech | 3.71B |
| Maxigen Biotech | 3.61B |
| ICARES Medicus | 3.45B |
| Nang Kuang Pharmaceutical | 3.23B |
| Crystalvue Medical | 1.88B |
| BenQ Medical Technology | 1.76B |
| Ttbio | 1.42B |